COSCIENS Share Capital Amendment Details Released for Shareholders
COSCIENS Biopharma has announced the next steps for its approved share capital amendment, setting out the timeline and shareholder impact of a planned share consolidation followed by an immediate split. The move affects common shareholders of the company, which trades on the Toronto Stock Exchange under the symbol CSCI and
